Website Search
In a previous post we noted the increasing importance of biologics as therapeutic agents, with 37% of the drugs approved by the FDA in 2017 being biologic entities. A recent article in Chemical & ...
Despite the billions of dollars spent annually discovering and developing new drugs, the global output of innovative new medicines is at its lowest point in several decades. This is not as illogical as it first sounds. As an industry we have become accustomed to expecting that financial investment will equate to positive outcomes - this in spite of the fact that we have seen more breathtaking failures in drug launches in the past ten years than ever before.